Literature DB >> 27513692

Coagulation and non-coagulation effects of thrombin.

J J N Posma1, J J Posthuma1, H M H Spronk2.   

Abstract

Thrombin is a multifunctional serine protease produced from prothrombin, and is a key regulator in hemostatic and non-hemostatic processes. It is the main effector protease in primary hemostasis by activating platelets, and plays a key role in secondary hemostasis. Besides its well-known functions in hemostasis, thrombin also plays a role in various non-hemostatic biological and pathophysiologic processes, predominantly mediated through activation of protease-activated receptors (PARs). Depending on several factors, such as the concentration of thrombin, the duration of activation, the location of PARs, the presence of coreceptors, and the formation of PAR heterodimers, activation of the receptor by thrombin can induce different cellular responses. Moreover, thrombin can have opposing effects in the same cell; it can induce both inflammatory and anti-inflammatory signals. Owing to the complexity of thrombin's signal transduction pathways, the exact mechanism behind the dichotomy of thrombin is yet still unknown. In this review, we highlight the hemostatic and non-hemostatic functions of thrombin, and specifically focus on the non-hemostatic dual role of thrombin under various conditions and in relation to cardiovascular disease.
© 2016 International Society on Thrombosis and Haemostasis.

Entities:  

Keywords:  atherosclerosis; blood coagulation; cardiovascular diseases; protease-activated receptors; thrombin

Mesh:

Substances:

Year:  2016        PMID: 27513692     DOI: 10.1111/jth.13441

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  42 in total

Review 1.  Basic Biology of Extracellular Matrix in the Cardiovascular System, Part 1/4: JACC Focus Seminar.

Authors:  Gonzalo Del Monte-Nieto; Jens W Fischer; Daniel J Gorski; Richard P Harvey; Jason C Kovacic
Journal:  J Am Coll Cardiol       Date:  2020-05-05       Impact factor: 24.094

Review 2.  Application and outlook of topical hemostatic materials: a narrative review.

Authors:  Yuting Zhong; Huayu Hu; Ningning Min; Yufan Wei; Xiangdong Li; Xiru Li
Journal:  Ann Transl Med       Date:  2021-04

3.  Trypsin activity governs increased susceptibility to pancreatitis in mice expressing human PRSS1R122H.

Authors:  Fu Gui; Yuebo Zhang; Jianhua Wan; Xianbao Zhan; Yao Yao; Yinghua Li; Ashley N Haddock; Ji Shi; Jia Guo; Jiaxiang Chen; Xiaohui Zhu; Brandy H Edenfield; Lu Zhuang; Cheng Hu; Ying Wang; Debabrata Mukhopadhyay; Evette S Radisky; Lizhi Zhang; Aurelia Lugea; Stephen J Pandol; Yan Bi; Baoan Ji
Journal:  J Clin Invest       Date:  2020-01-02       Impact factor: 14.808

4.  Effect of the FXa inhibitors Rivaroxaban and Apixaban on platelet activation in patients with atrial fibrillation.

Authors:  B Steppich; F Dobler; L C Brendel; G Hessling; S L Braun; A L Steinsiek; I Deisenhofer; A Hyseni; M Roest; I Ott
Journal:  J Thromb Thrombolysis       Date:  2017-05       Impact factor: 2.300

5.  The secret afterlife of platelets.

Authors:  Nicholas A Arce; Renhao Li
Journal:  Haematologica       Date:  2019-09       Impact factor: 9.941

6.  Elimination of the fibrinogen integrin αMβ2-binding motif improves renal pathology in mice with sickle cell anemia.

Authors:  Md Nasimuzzaman; Paritha I Arumugam; Eric S Mullins; Jeanne M James; Katherine VandenHeuvel; Marilou G Narciso; Maureen A Shaw; Sarah McGraw; Bruce J Aronow; Punam Malik
Journal:  Blood Adv       Date:  2019-05-14

Review 7.  Dual Anticoagulant and Antiplatelet Therapy for Coronary Artery Disease and Peripheral Artery Disease Patients.

Authors:  Nigel Mackman; Henri M H Spronk; George A Stouffer; Hugo Ten Cate
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-02-15       Impact factor: 8.311

Review 8.  The multifaceted role of fibrinogen in tissue injury and inflammation.

Authors:  James P Luyendyk; Jonathan G Schoenecker; Matthew J Flick
Journal:  Blood       Date:  2018-12-06       Impact factor: 22.113

9.  Antithrombotic Therapy: Prevention and Treatment of Atherosclerosis and Atherothrombosis.

Authors:  R H Olie; P E J van der Meijden; H M H Spronk; H Ten Cate
Journal:  Handb Exp Pharmacol       Date:  2022

Review 10.  Innate networking: Thrombotic microangiopathy, the activation of coagulation and complement in the sensitized kidney transplant recipient.

Authors:  Miriam Manook; Jean Kwun; Steven Sacks; Anthony Dorling; Nizam Mamode; Stuart Knechtle
Journal:  Transplant Rev (Orlando)       Date:  2018-02-10       Impact factor: 3.943

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.